CNBC Television
@CNBCtelevision·3.4M subscribers·157.5K videos
Moderna, Merck cancer vaccine shows promise in late-stage trial
Posted
August 19, 2026
Views
2,893
Likes
41
Comments
6
Engagement
August 19, 2026
2,893
41
6
1.62%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:34Now PlayingModerna CEO Stephane Bancel & Merck Research Laboratories President Dr. Dean Li join CNBC's "Squawk Box" to discuss Keytruda, an experimental personalized cancer vaccine that showed positive initial results in its first-ever late-stage trial.
Watch more in related video.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
